215 related articles for article (PubMed ID: 36303014)
1. Lingual Alveolar Soft Part Sarcoma in a 78-Year-Old Woman: A Case Report and Comprehensive Review of the Literature from 1952 to 2022.
Aksionau A; Dela Cruz NE; Meram AT; Cuellar-Saenz H; Aveni JR; Takei H
Head Neck Pathol; 2023 Mar; 17(1):265-274. PubMed ID: 36303014
[TBL] [Abstract][Full Text] [Related]
2. Lingual alveolar soft part sarcoma with absent TFE3 rearrangement.
Alshahrani S; Khan A
Cancer Rep (Hoboken); 2021 Feb; 4(1):e1298. PubMed ID: 33026169
[TBL] [Abstract][Full Text] [Related]
3. Is immunohistochemistry always the panacea to morphologic mimics? Two, distinct soft tissue tumors exhibiting alveolar pattern and TFE3 immunoreactivity.
Shah A; Rekhi B; Patil A
Indian J Pathol Microbiol; 2021; 64(4):767-770. PubMed ID: 34673600
[TBL] [Abstract][Full Text] [Related]
4. Lingual Alveolar Soft Part Sarcoma in a 1-Year-Old Infant: Youngest Reported Case With Characteristic ASPSCR1-TFE3 Fusion.
Ruffle A; Cameron M; Jonas N; Levine S; Mills C; Hook CE; Murray MJ
Pediatr Dev Pathol; 2019; 22(4):391-395. PubMed ID: 30744536
[TBL] [Abstract][Full Text] [Related]
5. Primary alveolar soft part sarcoma of the rectum resected by endoscopic submucosal dissection: A case report.
Nakayama A; Yokota A; Suzuki Y; Iizuka T; Fukawa T; Ushiku T; Takazawa Y; Fujii T
Pathol Int; 2020 Aug; 70(8):581-586. PubMed ID: 32515162
[TBL] [Abstract][Full Text] [Related]
6. Alveolar soft part sarcoma of lung: report of a unique case with emphasis on diagnostic utility of molecular genetic analysis for TFE3 gene rearrangement and immunohistochemistry for TFE3 antigen expression.
Zhao M; Rao Q; Wu C; Zhao Z; He X; Ru G
Diagn Pathol; 2015 Sep; 10():160. PubMed ID: 26369552
[TBL] [Abstract][Full Text] [Related]
7. Mammalian target of rapamycin pathway activity in alveolar soft part sarcoma.
Reis H; Hager T; Wohlschlaeger J; Bauer S; Katenkamp K; Katenkamp D; Baba HA
Hum Pathol; 2013 Oct; 44(10):2266-74. PubMed ID: 23871289
[TBL] [Abstract][Full Text] [Related]
8. Alveolar Soft Part Sarcoma of the Female Genital Tract: A Morphologic, Immunohistochemical, and Molecular Cytogenetic Study of 10 Cases With Emphasis on its Distinction From Morphologic Mimics.
Schoolmeester JK; Carlson J; Keeney GL; Fritchie KJ; Oliva E; Young RH; Nucci MR
Am J Surg Pathol; 2017 May; 41(5):622-632. PubMed ID: 28009610
[TBL] [Abstract][Full Text] [Related]
9. Technique for differentiating alveolar soft part sarcoma from other tumors in paraffin-embedded tissue: comparison of immunohistochemistry for TFE3 and CD147 and of reverse transcription polymerase chain reaction for ASPSCR1-TFE3 fusion transcript.
Tsuji K; Ishikawa Y; Imamura T
Hum Pathol; 2012 Mar; 43(3):356-63. PubMed ID: 21835426
[TBL] [Abstract][Full Text] [Related]
10. Exploring the Histogenesis and Diagnostic Strategy Using Immunoassay and RT-PCR in Alveolar Soft Part Sarcoma.
Ju X; Sun K; Liu R; Li S; Abulajiang G; Zou H; Lan J; Ren Y; Jiang J; Liang W; Pang L; Li F
Pathol Oncol Res; 2018 Jul; 24(3):593-600. PubMed ID: 28766250
[TBL] [Abstract][Full Text] [Related]
11. Alveolar soft part sarcoma: a bimarker diagnostic strategy using TFE3 immunoassay and ASPL-TFE3 fusion transcripts in paraffin-embedded tumor tissues.
Pang LJ; Chang B; Zou H; Qi Y; Jiang JF; Li HA; Hu WH; Chen YZ; Liu CX; Zhang WJ; Li F
Diagn Mol Pathol; 2008 Dec; 17(4):245-52. PubMed ID: 18382356
[TBL] [Abstract][Full Text] [Related]
12. [Alveolar soft part sarcoma in children: a clinicopathological study of 13 cases].
Wang LY; Jia C; Zhang M; An HB; Zhang N; Wang L; Fu LB; He LJ
Zhonghua Bing Li Xue Za Zhi; 2020 Feb; 49(2):134-138. PubMed ID: 32074725
[No Abstract] [Full Text] [Related]
13. Revisiting cytomorphology, including unusual features and clinical scenarios of 8 cases of alveolar soft part sarcoma with TFE3 immunohistochemical staining in 7 cases.
Rekhi B; Rao V; Ramadwar M
Cytopathology; 2021 Jan; 32(1):20-28. PubMed ID: 32853443
[TBL] [Abstract][Full Text] [Related]
14. Primary Alveolar Soft Part Sarcoma of Cheek: Report of a Case and Review of the Literature.
Hirose K; Naniwa K; Usami Y; Kohara M; Uchihashi T; Tanaka S; Yamada S; Iwamoto Y; Murakami S; Oya K; Fukuda Y; Hori Y; Morii E; Toyosawa S
Head Neck Pathol; 2021 Dec; 15(4):1426-1431. PubMed ID: 33840045
[TBL] [Abstract][Full Text] [Related]
15. Detection of the ASPSCR1-TFE3 gene fusion in paraffin-embedded alveolar soft part sarcomas.
Aulmann S; Longerich T; Schirmacher P; Mechtersheimer G; Penzel R
Histopathology; 2007 Jun; 50(7):881-6. PubMed ID: 17543078
[TBL] [Abstract][Full Text] [Related]
16. Detection of ASPL/TFE3 fusion transcripts and the TFE3 antigen in formalin-fixed, paraffin-embedded tissue in a series of 18 cases of alveolar soft part sarcoma: useful diagnostic tools in cases with unusual histological features.
Williams A; Bartle G; Sumathi VP; Meis JM; Mangham DC; Grimer RJ; Kindblom LG
Virchows Arch; 2011 Mar; 458(3):291-300. PubMed ID: 21279521
[TBL] [Abstract][Full Text] [Related]
17. Molecular cytogenetic analysis for TFE3 rearrangement in Xp11.2 renal cell carcinoma and alveolar soft part sarcoma: validation and clinical experience with 75 cases.
Hodge JC; Pearce KE; Wang X; Wiktor AE; Oliveira AM; Greipp PT
Mod Pathol; 2014 Jan; 27(1):113-27. PubMed ID: 23828314
[TBL] [Abstract][Full Text] [Related]
18. PEComa with ASPSCR1::TFE3 fusion: expanding the molecular genetic spectrum of TFE3-rearranged PEComa with an emphasis on overlap with alveolar soft part sarcoma.
Zhao M; Huang Y; Yin X; Xu J; Sun Y; Wang J
Histopathology; 2024 Feb; 84(3):482-491. PubMed ID: 37936565
[TBL] [Abstract][Full Text] [Related]
19. Primary renal neoplasms with the ASPL-TFE3 gene fusion of alveolar soft part sarcoma: a distinctive tumor entity previously included among renal cell carcinomas of children and adolescents.
Argani P; Antonescu CR; Illei PB; Lui MY; Timmons CF; Newbury R; Reuter VE; Garvin AJ; Perez-Atayde AR; Fletcher JA; Beckwith JB; Bridge JA; Ladanyi M
Am J Pathol; 2001 Jul; 159(1):179-92. PubMed ID: 11438465
[TBL] [Abstract][Full Text] [Related]
20. Correlation of Immunological and Molecular Profiles with Response to Crizotinib in Alveolar Soft Part Sarcoma: An Exploratory Study Related to the EORTC 90101 "CREATE" Trial.
Lee CJ; Modave E; Boeckx B; Kasper B; Aamdal S; Leahy MG; Rutkowski P; Bauer S; Debiec-Rychter M; Sciot R; Lambrechts D; Wozniak A; Schöffski P
Int J Mol Sci; 2022 May; 23(10):. PubMed ID: 35628499
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]